The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Methoxy-N-(pyridin-4-ylmethyl)-N-(3-((4-(trifluoromethyl)benzyl)oxy)benzyl)benzamide ID: ALA4163324
PubChem CID: 135187669
Max Phase: Preclinical
Molecular Formula: C29H25F3N2O3
Molecular Weight: 506.52
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(C(=O)N(Cc2ccncc2)Cc2cccc(OCc3ccc(C(F)(F)F)cc3)c2)cc1
Standard InChI: InChI=1S/C29H25F3N2O3/c1-36-26-11-7-24(8-12-26)28(35)34(18-21-13-15-33-16-14-21)19-23-3-2-4-27(17-23)37-20-22-5-9-25(10-6-22)29(30,31)32/h2-17H,18-20H2,1H3
Standard InChI Key: KHPIYKLJXXKAMD-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
13.0613 -19.4681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0601 -20.2876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7682 -20.6966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4778 -20.2872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4750 -19.4645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7664 -19.0592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1812 -19.0532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8904 -19.4592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5966 -19.0479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8935 -20.2764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3058 -19.4538 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5935 -18.2307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3023 -17.8234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2996 -17.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5898 -16.6003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8813 -17.0159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8875 -17.8310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6027 -20.6823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6042 -21.4998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3126 -21.9057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0197 -21.4943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0140 -20.6729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3050 -20.2708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7187 -20.2592 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4294 -20.6626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5856 -15.7831 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2913 -15.3709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1341 -20.2489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8430 -20.6561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5472 -20.2431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5417 -19.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8261 -19.0218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1248 -19.4372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2459 -19.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9571 -19.4128 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.2388 -18.1932 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.9515 -18.5973 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
8 10 1 0
9 11 2 0
9 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
22 24 1 0
24 25 1 0
15 26 1 0
26 27 1 0
25 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
31 34 1 0
34 35 1 0
34 36 1 0
34 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 506.52Molecular Weight (Monoisotopic): 506.1817AlogP: 6.53#Rotatable Bonds: 9Polar Surface Area: 51.66Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 5.02CX LogP: 5.79CX LogD: 5.79Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.26Np Likeness Score: -1.30
References 1. Wei C, Bajpai R, Sharma H, Heitmeier M, Jain AD, Matulis SM, Nooka AK, Mishra RK, Hruz PW, Schiltz GE, Shanmugam M.. (2017) Development of GLUT4-selective antagonists for multiple myeloma therapy., 139 [PMID:28837922 ] [10.1016/j.ejmech.2017.08.029 ]